Organisms | Evidence |
---|---|
Mus musculus (house mouse) | |
Rattus norvegicus (Norway rat) | |
Homo sapiens (human) | |
Drosophila melanogaster (fruit fly) | |
Streptococcus pneumoniae |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
B3GALT2 | UDP-Gal |
|
Lemieux |
|
Lemieux | |
B4GALT2 | UDP-Gal |
|
Benzyl-[beta] |
|
Benzyl-[beta] | |
B4GALT1 | UDP-Gal |
|
R |
|
R | |
B3GALT5 | UDP-Gal |
|
R |
|
R |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
B4GALT3 | UDP-Gal |
|
Benzyl-[beta] |
|
Benzyl-[beta] | |
B4GALT4 | UDP-Gal |
|
[beta]-1-Benzl |
|
[beta]-1-Benzl | |
B3GALT2 | UDP-Gal |
|
Lemieux |
|
Lemieux | |
B4GALT4 | UDP-Gal |
|
[beta]-1-4-methyl-umbelliferyl |
|
[beta]-1-4-methyl-umbelliferyl |
Pathway Name | Organism |
---|---|
Ficolins bind to repetitive carbohydrate structures on the target cell surface | Rattus norvegicus |
Initial triggering of complement | Sus scrofa |
Initial triggering of complement | Xenopus tropicalis |
Initial triggering of complement | Gallus gallus |
Initial triggering of complement | Homo sapiens |
Initial triggering of complement | Bos taurus |
Initial triggering of complement | Mus musculus |
Initial triggering of complement | Rattus norvegicus |
Initial triggering of complement | Canis familiaris |
Lectin pathway of complement activation | Sus scrofa |
RES 1b:b-dglc-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
PubMed ID | Title | First Author | Publication Date | Source |
---|---|---|---|---|
38775156 | Functional and structural investigation of a broadly neutralizing SARS-CoV-2 antibody | Chang YH | 2024 May 22 |
|
38771880 | Cryo-EM structures elucidate the multiligand receptor nature of megalin | Goto S | 2024 May 21 |
|
38773089 | Human CD4-binding site antibody elicited by polyvalent DNA prime-protein boost vaccine neutralizes cross-clade tier-2-HIV strains | Wang S | 2024 May 21 |
|
38773637 | O-GlcNAcylation: roles and potential therapeutic target for bone pathophysiology | Yan X | 2024 May 21 |
|
38769387 | Structure and mechanism of lysosome transmembrane acetylation by HGSNAT | Xu R | 2024 May 20 |
|
38753503 | Ultrapotent influenza hemagglutinin fusion inhibitors developed through SuFEx-enabled high-throughput medicinal chemistry | Kitamura S | 2024 May 16 |
|
38742627 | Structural basis for double-stranded RNA recognition by SID1 | Wang R | 2024 May 14 |
|
38670113 | Eliciting a single amino acid change by vaccination generates antibody protection against group 1 and group 2 influenza A viruses | Ray R | 2024 May 14 |
|
38624232 | Epitopes of an antibody that neutralizes a wide range of SARS-CoV-2 variants in a conserved subdomain 1 of the spike protein | Ishimaru H | 2024 May 14 |
|
38745047 | Synthesis and anti-inflammatory activities of two new N-acetyl glucosamine derivatives | Zhang Z | 2024 May 14 |
|
Title | Authors | Source | Publication Date | PubMed ID |
---|---|---|---|---|
Phosphorylation activates master growth regulator DELLA by promoting histone H2A binding at chromatin in Arabidopsis. |
|
Nat Commun | 2024 Sep 3 | 39227587 |
A protein O-GlcNAc glycosyltransferase regulates the antioxidative response in Yersinia pestis. |
|
Nat Commun | 2024 Aug 16 | 39152136 |
Polη O-GlcNAcylation governs genome integrity during translesion DNA synthesis. |
|
Nat Commun | 2017 Dec 5 | 29208956 |
Epithelial Mesenchymal Transition Induces Aberrant Glycosylation through Hexosamine Biosynthetic Pathway Activation. |
|
J Biol Chem | 2016 Jun 17 | 27129262 |
The making of a sweet modification: structure and function of O-GlcNAc transferase. |
|
J Biol Chem | 2014 Dec 12 | 25336649 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.2.1
Last updated: April 7, 2025